دورية أكاديمية
Umbilical Cord Blood Leptin and IL-6 in the Presence of Maternal Diabetes or Chorioamnionitis.
| العنوان: | Umbilical Cord Blood Leptin and IL-6 in the Presence of Maternal Diabetes or Chorioamnionitis. |
|---|---|
| المؤلفون: | Vasilakos LK; Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Steinbrekera B; Department of Pediatrics, University of South Dakota, Sioux Falls, SD, United States., Santillan DA; Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Santillan MK; Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Brandt DS; Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Dagle D; Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA, United States., Roghair RD; Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA, United States. |
| المصدر: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Feb 07; Vol. 13, pp. 836541. Date of Electronic Publication: 2022 Feb 07 (Print Publication: 2022). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Research Foundation] |
| مواضيع طبية MeSH: | Chorioamnionitis* , Diabetes, Gestational*, Female ; Fetal Blood/chemistry ; Humans ; Infant ; Infant, Newborn ; Interleukin-6 ; Leptin ; Pregnancy |
| مستخلص: | Diabetes during pregnancy is associated with elevated maternal insulin, leptin and IL-6. Within the placenta, IL-6 can further stimulate leptin production. Despite structural similarities and shared roles in inflammation, leptin and IL-6 have contrasting effects on neurodevelopment, and the relative importance of maternal diabetes or chorioamnionitis on fetal hormone exposure has not been defined. We hypothesized that there would be a positive correlation between IL-6 and leptin with progressively increased levels in pregnancies complicated by maternal diabetes and chorioamnionitis. To test this hypothesis, cord blood samples were obtained from 104 term infants, including 47 exposed to maternal diabetes. Leptin, insulin, and IL-6 were quantified by multiplex assay. Factors independently associated with hormone levels were identified by univariate and multivariate linear regression. Unlike IL-6, leptin and insulin were significantly increased by maternal diabetes. Maternal BMI and birth weight were independent predictors of leptin and insulin with birth weight the strongest predictor of leptin. Clinically diagnosed chorioamnionitis and neonatal sepsis were associated with increased IL-6 but not leptin. Among appropriate for gestational age infants without sepsis, IL-6 and leptin were strongly correlated (R=0.6, P<0.001). In summary, maternal diabetes and birth weight are associated with leptin while chorioamnionitis is associated with IL-6. The constraint of the positive association between leptin and IL-6 to infants without sepsis suggests that the term infant and placenta may have a limited capacity to increase cord blood levels of the neuroprotective hormone leptin in the presence of increased cord blood levels of the potential neurotoxin IL-6. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2022 Vasilakos, Steinbrekera, Santillan, Santillan, Brandt, Dagle and Roghair.) |
| References: | J Immunol. 2002 Jan 15;168(2):875-82. (PMID: 11777985) Front Endocrinol (Lausanne). 2021 Jul 22;12:706369. (PMID: 34367073) Eur J Immunol. 2002 Feb;32(2):552-60. (PMID: 11828372) Brain Behav Immun. 2017 May;62:11-23. (PMID: 27838335) Horm Metab Res. 1999 Aug;31(8):467-71. (PMID: 10494872) Metabolism. 2015 Jan;64(1):114-30. (PMID: 25092133) Obstet Gynecol Sci. 2020 Jul;63(4):407-416. (PMID: 32689769) Diabetes Care. 2021 May;44(5):1194-1202. (PMID: 33619125) N Engl J Med. 2008 May 8;358(19):1991-2002. (PMID: 18463375) PLoS One. 2019 Nov 7;14(11):e0224863. (PMID: 31697751) PLoS One. 2014 Apr 14;9(4):e94680. (PMID: 24732937) J Clin Endocrinol Metab. 1997 Dec;82(12):4080-2. (PMID: 9398717) J Clin Invest. 1997 May 15;99(10):2398-404. (PMID: 9153282) Pediatrics. 2002 Oct;110(4):673-80. (PMID: 12359779) Mol Hum Reprod. 2000 Aug;6(8):763-9. (PMID: 10908288) Nature. 1997 May 8;387(6629):206-9. (PMID: 9144295) Am J Perinatol. 1998 Apr;15(4):243-7. (PMID: 9565222) Brain Behav Immun. 2011 May;25(4):604-15. (PMID: 21195166) Science. 2004 Apr 2;304(5667):108-10. (PMID: 15064420) Pediatr Res. 2011 May;69(5 Pt 1):406-12. (PMID: 21258265) Am J Physiol Endocrinol Metab. 2001 Aug;281(2):E326-34. (PMID: 11440909) Diabetes Care. 2017 Jul;40(7):902-910. (PMID: 28637888) Obesity (Silver Spring). 2013 Jan;21(1):E124-30. (PMID: 23505192) J Clin Endocrinol Metab. 2006 Oct;91(10):4137-43. (PMID: 16849405) J Clin Endocrinol Metab. 2017 Feb 1;102(2):499-506. (PMID: 27841944) Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:94-9. (PMID: 24965987) Obesity (Silver Spring). 2013 Jan;21(1):210-6. (PMID: 23505188) N Engl J Med. 1990 Aug 2;323(5):309-15. (PMID: 2195347) J Endocrinol. 2016 Nov;231(2):R47-R60. (PMID: 27613336) Placenta. 2001 Apr;22 Suppl A:S45-50. (PMID: 11312628) Immunity. 2007 Feb;26(2):241-55. (PMID: 17307705) J Endocrinol Invest. 2004 Jan;27(1):18-23. (PMID: 15053238) Diabetes. 1998 May;47(5):847-50. (PMID: 9588462) Nat Med. 1995 Sep;1(9):953-6. (PMID: 7585224) Endocrinology. 2003 Oct;144(10):4350-3. (PMID: 12959996) Pediatr Res. 2000 Nov;48(5):646-51. (PMID: 11044486) Clin Chem Lab Med. 2002 Nov;40(11):1114-7. (PMID: 12521228) Medicine (Baltimore). 2020 Oct 2;99(40):e22152. (PMID: 33019392) Reprod Sci. 2015 Feb;22(2):189-97. (PMID: 24899470) Immunity. 2000 Dec;13(6):805-15. (PMID: 11163196) J Biol Chem. 1996 Feb 2;271(5):2365-8. (PMID: 8576190) BJOG. 2002 May;109(5):534-9. (PMID: 12066943) J Exp Med. 1997 Jan 6;185(1):171-5. (PMID: 8996253) Pediatr Res. 1996 Jun;39(6):976-9. (PMID: 8725257) Cell Immunol. 2000 Jan 10;199(1):15-24. (PMID: 10675271) Int J Obes (Lond). 2018 Apr;42(4):608-617. (PMID: 29026216) Cell Metab. 2005 Jun;1(6):371-8. (PMID: 16054086) N Engl J Med. 1996 Feb 1;334(5):292-5. (PMID: 8532024) J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56. (PMID: 15181022) |
| فهرسة مساهمة: | Keywords: adipokine cytokine; development; inflammation; insulin; neonatal; obesity; sepsis |
| المشرفين على المادة: | 0 (Interleukin-6) 0 (Leptin) |
| تواريخ الأحداث: | Date Created: 20220224 Date Completed: 20220331 Latest Revision: 20220401 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC8859102 |
| DOI: | 10.3389/fendo.2022.836541 |
| PMID: | 35197933 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2022.836541 |